Published in Mediators Inflamm on January 01, 2006
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (2001) 11.23
Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med (1999) 6.91
Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol (2001) 5.87
Prostaglandins as modulators of immunity. Trends Immunol (2002) 4.15
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A (2005) 3.32
A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem (2005) 2.76
NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology (2000) 2.43
Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest (1996) 2.31
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest (2000) 2.27
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology (2002) 2.18
Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J Clin Invest (1993) 2.15
Concern A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc Natl Acad Sci U S A (2004) 2.13
Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med (1996) 1.92
Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem (1994) 1.76
Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J Biol Chem (1980) 1.66
Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat (2002) 1.56
Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. Br J Pharmacol (1999) 1.54
Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat. Gastroenterology (1988) 1.50
Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol (2004) 1.29
Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: directing the tone of the intestinal immune response. J Immunol (2001) 1.27
Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2000) 1.08
Lipoxins inhibit microvascular inflammatory actions of leukotriene B4. Adv Exp Med Biol (1991) 1.06
Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol (1998) 1.05
Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells. Cell Immunol (2001) 1.04
Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. J Immunol (2001) 1.02
Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology (1989) 0.98
Modulation of T-cell cytokine secretion by accessory cell-derived products. Eur Respir J Suppl (1996) 0.96
Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen. J Immunol (1994) 0.92
Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis. Kidney Int (1994) 0.91
15-Deoxy-Delta12,1412,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation. J Immunol (1999) 0.87
Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2. Am J Physiol Gastrointest Liver Physiol (2003) 0.83
Prostaglandin receptors of the EP2 and EP4 subtypes regulate B lymphocyte activation and differentiation to IgE-secreting cells. Adv Exp Med Biol (1997) 0.82
Human 15-lipoxygenase: a potential effector molecule for interleukin-4. Adv Prostaglandin Thromboxane Leukot Res (1994) 0.82
Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study. Nutr Clin Pract (2012) 2.10
Early Postoperative Decrease of Serum Albumin Predicts Surgical Outcome in Patients Undergoing Colorectal Resection. Dis Colon Rectum (2017) 1.99
Frequency and risk factors of postoperative recurrence of Crohn's disease after intestinal resection in the Chinese population. J Gastrointest Surg (2012) 1.52
Bacteremia in patients with acute pancreatitis as revealed by 16S ribosomal RNA gene-based techniques*. Crit Care Med (2013) 1.44
Temporary rapid bowel ligation as a damage control adjunct improves survival in a hypothermic traumatic shock swine model with multiple bowel perforations. J Surg Res (2012) 1.40
Immunologic response after laparoscopic colon cancer operation within an enhanced recovery program. J Gastrointest Surg (2012) 1.25
Disruption of tight junctions during polymicrobial sepsis in vivo. J Pathol (2009) 1.13
Bone marrow mesenchymal stem cells reduce intestinal ischemia/reperfusion injuries in rats. J Surg Res (2009) 1.10
Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr (2008) 1.10
Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer (2007) 1.08
Severe acute pancreatitis during pregnancy: eleven years experience from a surgical intensive care unit. Dig Dis Sci (2011) 1.04
Surgical treatment and perioperative management of idiopathic abdominal cocoon: single-center review of 65 cases. World J Surg (2014) 1.04
Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol (2007) 1.03
Fish oil-supplemented parenteral nutrition in severe acute pancreatitis patients and effects on immune function and infectious risk: a randomized controlled trial. Inflammation (2009) 1.03
Comparing outcomes between side-to-side anastomosis and other anastomotic configurations after intestinal resection for patients with Crohn's disease: a meta-analysis. World J Surg (2013) 1.03
The intestinal fatty acid binding protein diagnosing gut dysfunction in acute pancreatitis: a pilot study. Pancreas (2010) 1.01
Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res (2006) 1.00
Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol (2014) 0.99
Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer. Ann Clin Lab Sci (2008) 0.98
Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis (2011) 0.98
Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J Lipid Res (2005) 0.98
Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine. Cytotherapy (2011) 0.96
Epithelial-specific blockade of MyD88-dependent pathway causes spontaneous small intestinal inflammation. Clin Immunol (2010) 0.95
Percutaneous cholecystostomy is a definitive treatment for acute cholecystitis in elderly high-risk patients. Am Surg (2013) 0.95
Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas (2008) 0.95
Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease. PLoS One (2012) 0.94
The suppressive effect of triptolide on chronic colitis and TNF-alpha/TNFR2 signal pathway in interleukin-10 deficient mice. Clin Immunol (2008) 0.94
Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis. FEBS J (2007) 0.93
Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension. J Hepatobiliary Pancreat Sci (2010) 0.92
Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine. J Int Med Res (2013) 0.92
Identification of a surface protein from Lactobacillus reuteri JCM1081 that adheres to porcine gastric mucin and human enterocyte-like HT-29 cells. Curr Microbiol (2008) 0.92
Management of enterocutaneous fistulas: 30-year clinical experience. Chin Med J (Engl) (2003) 0.92
Exclusive enteral nutritional therapy can relieve inflammatory bowel stricture in Crohn's disease. J Clin Gastroenterol (2014) 0.92
Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn's disease. Nutr Clin Pract (2013) 0.91
Mean platelet volume: a controversial marker of disease activity in Crohn's disease. Eur J Med Res (2012) 0.91
Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch Biochem Biophys (2007) 0.91
Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells. Eur J Pharm Sci (2010) 0.91
Enteropathogenic Escherichia coli changes distribution of occludin and ZO-1 in tight junction membrane microdomains in vivo. Microb Pathog (2009) 0.91
Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie (2006) 0.91
The outcome of initial percutaneous drainage versus surgical drainage for intra-abdominal abscesses in Crohn's disease. Int J Colorectal Dis (2011) 0.91
Efficacy of T2 in active Crohn's disease: a prospective study report. Dig Dis Sci (2007) 0.90
Acute pancreatitis in pregnancy. Acta Obstet Gynecol Scand (2011) 0.90
Altered distribution of tight junction proteins after intestinal ischaemia/reperfusion injury in rats. J Cell Mol Med (2009) 0.90
Duodenal perforation due to a kink in a nasojejunal feeding tube in a patient with severe acute pancreatitis: a case report. J Med Case Rep (2010) 0.90
Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease. J Gastroenterol Hepatol (2015) 0.90
The impact of perioperative glutamine-supplemented parenteral nutrition on outcomes of patients undergoing abdominal surgery: a meta-analysis of randomized clinical trials. Am Surg (2013) 0.89
Early enteral nutrition improves outcomes of open abdomen in gastrointestinal fistula patients complicated with severe sepsis. Nutr Clin Pract (2011) 0.89
A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery. Dis Colon Rectum (2015) 0.89
Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF-κB signaling pathway. Fitoterapia (2011) 0.89
Polyunsaturated docosahexaenoic acid suppresses oxidative stress induced endothelial cell calcium influx by altering lipid composition in membrane caveolar rafts. Prostaglandins Leukot Essent Fatty Acids (2010) 0.88
The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model. J Cardiothorac Surg (2013) 0.88
The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells. Fitoterapia (2009) 0.88
Growth hormone increases lung NF-kappaB activation and lung microvascular injury induced by lipopolysaccharide in rats. Ann Clin Lab Sci (2002) 0.88
Use of 18S ribosomal DNA polymerase chain reaction-denaturing gradient gel electrophoresis to study composition of fungal community in 2 patients with intestinal transplants. Hum Pathol (2012) 0.87
Glutamine reduces TNF-alpha by enhancing glutathione synthesis in lipopolysaccharide-stimulated alveolar epithelial cells of rats. Inflammation (2008) 0.87
Dynamic alteration of the colonic microbiota in intestinal ischemia-reperfusion injury. PLoS One (2012) 0.87
Invasion of enteropathogenic Escherichia coli into host cells through epithelial tight junctions. FEBS J (2008) 0.86
Continuous veno venous hemofiltration in treatment of acute necrotizing pancreatitis. Chin Med J (Engl) (2003) 0.86
Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and oxidative stress after hemorrhagic shock and resuscitation in rats. Inflammation (2009) 0.86
Berberine ameliorates pro-inflammatory cytokine-induced endoplasmic reticulum stress in human intestinal epithelial cells in vitro. Inflammation (2012) 0.86
Ultrasound as a diagnostic tool in detecting active Crohn's disease: a meta-analysis of prospective studies. Eur Radiol (2013) 0.86
An innovative technique for intra-abdominal abscess drainage using a sump drain by trocar puncture. Am Surg (2011) 0.86
Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model. Artif Organs (2013) 0.86
Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant. PLoS One (2011) 0.86
n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines. Mol Immunol (2007) 0.86
PepT1 mediates colon damage by transporting fMLP in rats with bowel resection. J Surg Res (2006) 0.86
A modified model of the abdominal compartment syndrome. J Trauma (2011) 0.85
Hydroxyethyl starch 130/0.4 prevents the early pulmonary inflammatory response and oxidative stress after hemorrhagic shock and resuscitation in rats. Int Immunopharmacol (2009) 0.85
N-3 PUFAs attenuate ischemia/reperfusion induced intestinal barrier injury by activating I-FABP-PPARγ pathway. Clin Nutr (2012) 0.85
Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats. Microsurgery (2008) 0.85
Nonthyroidal illness syndrome in enterocutaneous fistulas. Am J Surg (2013) 0.84
Risk Factors and Outcome for Massive Intra-Abdominal Bleeding Among Patients With Infected Necrotizing Pancreatitis. Medicine (Baltimore) (2015) 0.84
Triptolide induces suppressor of cytokine signaling-3 expression and promotes lamina propria mononuclear cells apoptosis in Crohn's colitis. Int Immunopharmacol (2013) 0.84
Continuous renal replacement therapy (CRRT) attenuates myocardial inflammation and mitochondrial injury induced by venovenous extracorporeal membrane oxygenation (VV ECMO) in a healthy piglet model. Inflammation (2013) 0.83
Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation. Inflammation (2012) 0.83
Growth hormone receptor expression in human colorectal cancer. Dig Dis Sci (2004) 0.83
Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis. PLoS One (2013) 0.83
Triptolide ameliorates ileocolonic anastomosis inflammation in IL-10 deficient mice by mechanism involving suppression of miR-155/SHIP-1 signaling pathway. Mol Immunol (2013) 0.83
The role of oxygen-free radical in the apoptosis of enterocytes and bacterial translocation in abdominal compartment syndrome. Free Radic Res (2009) 0.83
Temporal variations of the ileal microbiota in intestinal ischemia and reperfusion. Shock (2013) 0.83
Nonthyroidal illness syndrome: is it far away from Crohn's disease? J Clin Gastroenterol (2013) 0.82
Percutaneous catheter drainage for infective pancreatic necrosis: is it always the first choice for all patients? Pancreas (2012) 0.82
Epidermal growth factor promotes proliferation and improves restoration after intestinal ischemia-reperfusion injury in rats. Inflammation (2013) 0.82
Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults. Clin Nutr (2011) 0.82
Microscopic and ultrastructural changes of the intestine in abdominal compartment syndrome. J Invest Surg (2009) 0.82
Hydroxyethyl starch 130/0.4 augments healing of colonic anastomosis in a rat model of peritonitis. Am J Surg (2009) 0.82
Treatment of Slow Transit Constipation With Fecal Microbiota Transplantation: A Pilot Study. J Clin Gastroenterol (2016) 0.82
Anti-inflammatory effect of ginsenoside Rb1 contributes to the recovery of gastrointestinal motility in the rat model of postoperative ileus. Biol Pharm Bull (2014) 0.82
Isolation of adhesive strains and evaluation of the colonization and immune response by Lactobacillus plantarum L2 in the rat gastrointestinal tract. Int J Food Microbiol (2009) 0.82
Rehabilitation therapy for short bowel syndrome. Chin Med J (Engl) (2002) 0.82
The role of sphingosine kinase 1 in patients with severe acute pancreatitis. Ann Surg (2012) 0.82
Effect of the combination of fibrin glue and growth hormone on intestinal anastomoses in a pig model of traumatic shock associated with peritonitis. World J Surg (2009) 0.82
Temporary intravascular shunts used as a damage control surgery adjunct in complex vascular injury: collective review. Injury (2008) 0.82
The respective role of medical and surgical therapy for enterovesical fistula in Crohn's disease. J Clin Gastroenterol (2014) 0.82
Redistribution of tight junction proteins during EPEC infection in vivo. Inflammation (2012) 0.82
CONSORT: Different End-Points of Preoperative Nutrition and Outcome of Bowel Resection of Crohn Disease: A Randomized Clinical Trial. Medicine (Baltimore) (2015) 0.81
Exogenous C3 protein enhances the adaptive immune response to polymicrobial sepsis through down-regulation of regulatory T cells. Int Immunopharmacol (2011) 0.81